Collegium Pharmaceutical (COLL) Short Interest Ratio & Short Volume → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free COLL Stock Alerts $37.86 -0.20 (-0.53%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Collegium Pharmaceutical Short Interest DataCurrent Short Volume6,990,000 sharesPrevious Short Volume7,120,000 sharesChange Vs. Previous Month-1.83%Dollar Volume Sold Short$245.63 millionShort Interest Ratio / Days to Cover17.3Last Record DateApril 15, 2024Outstanding Shares32,706,000 sharesFloat Size30,580,000 sharesShort Percent of Float22.86%Today's Trading Volume363,953 sharesAverage Trading Volume415,390 sharesToday's Volume Vs. Average88% Short Selling Collegium Pharmaceutical ? Sign up to receive the latest short interest report for Collegium Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCOLL Short Interest Over TimeCOLL Days to Cover Over TimeCOLL Percentage of Float Shorted Over Time Ad Stansberry ResearchThings Are Not Normal in America – Here’s What to DoGet Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. Collegium Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,990,000 shares $245.63 million -1.8%22.9%17.3 $35.14 3/31/20247,120,000 shares $276.40 million +1.6%23.3%17.5 $38.82 3/15/20247,010,000 shares $274.02 million +4.3%22.9%15.7 $39.09 2/29/20246,720,000 shares $246.69 million -1.5%22.0%15.4 $36.71 2/15/20246,820,000 shares $231.54 million +0.9%22.3%16.1 $33.95 1/31/20246,760,000 shares $222.81 million +6.5%21.4%16.3 $32.96 Get the Latest News and Ratings for COLL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 1/15/20246,350,000 shares $206.44 million -0.5%20.1%15.2 $32.51 12/31/20236,380,000 shares $196.38 million -3.6%20.2%15.9 $30.78 12/15/20236,620,000 shares $196.22 million +0.3%20.9%18.5 $29.64 11/30/20236,600,000 shares $169.16 million -2.9%20.8%21.7 $25.63 11/15/20236,800,000 shares $169.73 million +13.1%21.5%22.9 $24.96 10/31/20236,010,000 shares $130.78 million -7.3%17.8%22.3 $21.76 10/15/20236,480,000 shares $141.91 million +0.2%19.2%21.2 $21.90 9/30/20236,470,000 shares $144.60 million -6.5%19.2%21.8 $22.35 9/15/20236,920,000 shares $156.74 million -6.5%20.5%23.6 $22.65 8/31/20237,400,000 shares $173.31 million -3.1%21.9%23.7 $23.42 8/15/20237,640,000 shares $181.83 million +28.6%22.6%24.6 $23.80 7/31/20235,940,000 shares $135.19 million -9.6%17.6%18.7 $22.76 7/15/20236,570,000 shares $141.98 million -1.5%19.5%21.2 $21.61 6/30/20236,670,000 shares $143.34 million +2.0%19.8%20.2 $21.49 6/15/20236,540,000 shares $144.73 million +4.1%19.4%19.4 $22.13 5/31/20236,280,000 shares $138.60 million -1.3%18.6%19.3 $22.07 5/15/20236,360,000 shares $149.46 million +2.1%19.2%17.7 $23.50 4/30/20236,230,000 shares $144.97 million +0.7%18.7%13.5 $23.27 4/15/20236,190,000 shares $141.94 million +6.2%18.9%13.9 $22.93 3/31/20235,830,000 shares $139.86 million +2.3%17.8%12.6 $23.99 3/15/20235,700,000 shares $134.81 million +4.2%17.4%11.9 $23.65 2/28/20235,470,000 shares $145.12 million +16.1%16.8%11.7 $26.53 2/15/20234,710,000 shares $128.44 million +19.5%14.5%10.8 $27.27 1/31/20233,940,000 shares $110.64 million -0.8%12.2%9.4 $28.08 1/15/20233,970,000 shares $114.06 million +8.5%12.3%13 $28.73 12/30/20223,660,000 shares $84.91 million +2.0%11.3%13 $23.20 12/15/20223,590,000 shares $80.74 million -4.5%11.1%15.8 $22.49 11/30/20223,760,000 shares $82.23 million -4.3%11.6%16.5 $21.87 11/15/20223,930,000 shares $84.61 million +2.3%12.2%17.1 $21.53 10/31/20223,840,000 shares $68.89 million -1.5%11.9%17.3 $17.94 10/15/20223,900,000 shares $69.77 million +2.6%11.9%17.7 $17.89 9/30/20223,800,000 shares $60.88 million +3.0%11.6%16.5 $16.02 9/15/20223,690,000 shares $66.75 million +1.9%11.3%14.4 $18.09 8/31/20223,620,000 shares $63.64 million -1.9%11.1%13.8 $17.58The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. COLL Short Interest - Frequently Asked Questions What is Collegium Pharmaceutical's current short interest? Short interest is the volume of Collegium Pharmaceutical shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 6,990,000 shares of COLL short. 22.86% of Collegium Pharmaceutical's shares are currently sold short. Learn More on Collegium Pharmaceutical's current short interest. What is a good short interest ratio for Collegium Pharmaceutical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. COLL shares currently have a short interest ratio of 17.0. Learn More on Collegium Pharmaceutical's short interest ratio. Which institutional investors are shorting Collegium Pharmaceutical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Collegium Pharmaceutical: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Collegium Pharmaceutical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.86% of Collegium Pharmaceutical's floating shares are currently sold short. Is Collegium Pharmaceutical's short interest increasing or decreasing? Collegium Pharmaceutical saw a decrease in short interest in April. As of April 15th, there was short interest totaling 6,990,000 shares, a decrease of 1.8% from the previous total of 7,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Collegium Pharmaceutical's float size? Collegium Pharmaceutical currently has issued a total of 32,710,000 shares. Some of Collegium Pharmaceutical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Collegium Pharmaceutical currently has a public float of 30,580,000 shares. How does Collegium Pharmaceutical's short interest compare to its competitors? 22.86% of Collegium Pharmaceutical's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Collegium Pharmaceutical: Mirum Pharmaceuticals, Inc. (18.21%), MannKind Co. (13.21%), Pacira BioSciences, Inc. (7.42%), Spyre Therapeutics, Inc. (10.55%), Verona Pharma plc (7.68%), AbCellera Biologics Inc. (11.25%), Belite Bio, Inc (0.12%), Prothena Co. plc (12.34%), Gyre Therapeutics, Inc. (1.30%), Ironwood Pharmaceuticals, Inc. (13.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Collegium Pharmaceutical stock? Short selling COLL is an investing strategy that aims to generate trading profit from Collegium Pharmaceutical as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Collegium Pharmaceutical? A short squeeze for Collegium Pharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COLL, which in turn drives the price of the stock up even further. How often is Collegium Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COLL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MIRM Short Interest MNKD Short Interest PCRX Short Interest SYRE Short Interest VRNA Short Interest ABCL Short Interest BLTE Short Interest PRTA Short Interest GYRE Short Interest IRWD Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:COLL) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings